正在加载视频...

视频加载失败

返回首页

Dr. Patrick Soon-Shiong just showed Chris Cuomo dramatic before-and-after brain scans of late-stage tumor patients who failed chemo, radiation, and surgery — achieving complete remission with ANKTIVA. No chemo. No radiation. Tumors shrinking dramatically in months. He says: “We got FDA approval to treat patients who failed everything… and...

newstart_2024's profile picture

Camus

460,750 subscribers

281,696 次观看 • 4 个月前 •via X (Twitter)

健康养生新闻政治科学技术
LIVE

Anya Rossi• Live Now

Private livecam show

0 条评论

暂无评论

原始帖子的评论将显示在这里

相关视频

This 70-second clip is spreading like wildfire for a reason. Chris Cuomo asks the question every cancer patient fears: “Are you just giving people false hope?” Dr. Patrick Soon-Shiong doesn’t answer with words. He pulls up actual brain scans. Patient: failed surgery, failed radiation, failed chemo. Result after Anktiva + BioShield protocol: tumor visibly shrinking in months — with NO chemo and NO radiation.“ These aren’t anecdotes. These are scans.” The moment at 0:52-1:00 will stop you in your tracks. This is the same treatment that started saving “no-hope” patients back in 2015-2017 and just keeps delivering complete remissions years later. Watch the full 1:11 clip, see the proof with your own eyes, then tell me: Is this the turning point we’ve all been waiting for? Patients, doctors, caregivers — your voice matters. Drop your reaction below. This deserves to be seen by millions. (Always consult your physician — not medical advice)
1:11

This 70-second clip is spreading like wildfire for a reason. Chris Cuomo asks the question every cancer patient fears: “Are you just giving people false hope?” Dr. Patrick Soon-Shiong doesn’t answer with words. He pulls up actual brain scans. Patient: failed surgery, failed radiation, failed chemo. Result after Anktiva + BioShield protocol: tumor visibly shrinking in months — with NO chemo and NO radiation.“ These aren’t anecdotes. These are scans.” The moment at 0:52-1:00 will stop you in your tracks. This is the same treatment that started saving “no-hope” patients back in 2015-2017 and just keeps delivering complete remissions years later. Watch the full 1:11 clip, see the proof with your own eyes, then tell me: Is this the turning point we’ve all been waiting for? Patients, doctors, caregivers — your voice matters. Drop your reaction below. This deserves to be seen by millions. (Always consult your physician — not medical advice)

Camus

237,819 次观看 • 8 个月前

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.
3:35

Of all the casualties in the war on cancer, the most critical have been the most ignored: your NK and T cells. As Dr. Patrick Soon-Shiong explains, while oncology has long treated the anemia and neutropenia caused by chemotherapy, it has overlooked the destruction of the very immune cells that fight cancer. For 35 years, there was no treatment for this catastrophic side effect. That era is over. Dr. Soon-Shiong announces ANKTIVA, the first FDA-approved therapy proven to activate NK cells, T cells, and memory T cells. The result? Documented complete responses in bladder cancer patients, free of disease for over nine years. This breakthrough shatters a long-standing medical blind spot. Whether from chemo, radiation, or a severe viral infection, the body's primary defense is often wiped out. ANKTIVA represents a paradigm shift—from solely attacking disease to actively re-arming the patient's own immune system. The future of medicine is not just fighting the enemy, but empowering the army within.

Camus

55,260 次观看 • 9 个月前

A powerful patient story from Dr. Patrick Soon-Shiong's discussion with Sean Spicer: A woman with advanced lung cancer—24 tumors (including thyroid), failed chemo/radiation, given 6-8 weeks to live—joined a trial combining Anktiva (N-803) with Keytruda. After stopping chemo, she felt immediate improvement: eating normally, no weakness, walking, gym, enjoying granddaughter, even running a festival. Scans showed shrinking tumors, thyroid gone; now 4+ years later, thriving with quality of life. Anktiva (FDA-approved 2024 for specific bladder cancer) boosts natural killer cells and T cells—key to immune attack on cancer. Soon-Shiong argues bureaucracy blocks broader access: Right to Try (advocated by Trump/Johnson) gets subverted by FDA delays/IRB hurdles; why require cancer-specific trials when NK-cell boosting helps regardless (like Epogen for anemia)? He's expanding to Canada, Europe, South Africa—where patients see responses in leukemia, etc.—while criticizing US red tape as life-costing. Inspiring remission vs. regulatory frustration: Does this highlight breakthrough potential or need for faster pathways? What's your take on access to immunotherapies like this? Real stories welcome below.
4:51

A powerful patient story from Dr. Patrick Soon-Shiong's discussion with Sean Spicer: A woman with advanced lung cancer—24 tumors (including thyroid), failed chemo/radiation, given 6-8 weeks to live—joined a trial combining Anktiva (N-803) with Keytruda. After stopping chemo, she felt immediate improvement: eating normally, no weakness, walking, gym, enjoying granddaughter, even running a festival. Scans showed shrinking tumors, thyroid gone; now 4+ years later, thriving with quality of life. Anktiva (FDA-approved 2024 for specific bladder cancer) boosts natural killer cells and T cells—key to immune attack on cancer. Soon-Shiong argues bureaucracy blocks broader access: Right to Try (advocated by Trump/Johnson) gets subverted by FDA delays/IRB hurdles; why require cancer-specific trials when NK-cell boosting helps regardless (like Epogen for anemia)? He's expanding to Canada, Europe, South Africa—where patients see responses in leukemia, etc.—while criticizing US red tape as life-costing. Inspiring remission vs. regulatory frustration: Does this highlight breakthrough potential or need for faster pathways? What's your take on access to immunotherapies like this? Real stories welcome below.

Camus

32,930 次观看 • 6 个月前

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”
8:29

🚨ImmunityBio’s Anktiva: A New FDA-Approved Immunotherapy for certain bladder cancer. They are also developing treatments that may reduce the need for strong chemo, for blood cancer, lung cancer, brain cancer, and more. Broader approvals may take time. Someone call the President and fast-track this. Dr. Pat Soon-Shiong leads development beyond typical biotech efforts. Most cancer medicines, like chemotherapy, work by poisoning fast-growing cells to kill the cancer. This also hurts healthy cells, causing side effects like hair loss and weakness. Anktiva is different. It is an immunotherapy that wakes up your body’s own immune cells; natural killer cells and T cells to hunt and destroy cancer cells themselves. It acts like a booster shot for your immune system, using a protein called IL-15 to make these cells multiply and remember how to fight cancer long-term. ImmunityBio is different from most companies because of 3 big unique things: 1. They wake up 3 kinds of fighter cells at the same time: • NK cells (natural killers) • CD8 T cells (main attackers) • CD4 T cells (helpers) These three work together like a basketball team. This makes the body remember the cancer for a long time (maybe years). 2. They have a special cell line called NK-92. → It’s like buying frozen pizza instead of making dough from scratch every time. Doctors can just thaw it and give it to any patient. No need to take cells from the sick kid, customize them, and make them super weak with hospital chemo (that’s what normal CAR-T does). 3. Their medicine Anktiva gives a long, steady boost to the immune cells. Older drugs (like IL-2) gave a short, crazy boost that made people very sick. Anktiva is seems safer, so far. Exciting to follow the development. Interview: Chris Cuomo (NewsNation) — “Killing Cancer”

Black Panther Capital

40,249 次观看 • 6 个月前

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.
5:24

A Cancer Breakthrough That Changes Everything In a stunning medical advance, Dr. Patrick Soon-Shiong reveals a platform technology achieving near-complete responses in patients with terminal cancers—including brain, pancreatic, and head & neck tumors—after all other treatments failed. This isn't a traditional chemo or radiation. It's a dual approach that empowers the body's own immune system. Here’s the revolutionary breakdown: 1. The "BioShield" Injection: The key is a stabilized form of IL-15 (Interleukin-15), a protein that acts as "food" for your Natural Killer (NK) cells. The NIH tried for a decade to develop IL-15 but failed because it naturally lasts only 2 minutes in the body. Dr. Soon-Shiong's team engineered it to last for 7 days with a simple 5-minute subcutaneous injection, continuously proliferating the patient's NK cells. 2. The Combined Infusion: Patients receive this "BioShield" injection along with an infusion of powerful NK cells, creating a targeted army to attack the cancer. The Proven Results: - Metastatic Pancreatic Cancer: Patients alive 6 years later. - Merkel Cell Carcinoma: Patients surviving 9 years. - Bladder Cancer: Approved by the FDA in April 2024, with patients disease-free for 10 years. - Lung Cancer: In new trials, the therapy has tripled survival for patients who failed everything, including chemo and checkpoint inhibitors. The therapy is also being used preemptively. The NCI has designated it for a trial on patients with Lynch syndrome (1 in 280 Americans), who have an 80% higher risk of cancers, to provide a "Cancer BioShield." The data is based on experience with over 8,000 patients. The challenge now is regulatory. Despite its pan-tumor potential, the current system requires a separate 10-year, 700,000-page approval process for each cancer type. This is a paradigm shift. We don't ask what kind of anemia you have before a blood transfusion. The body needs NK cells and T-cells to fight cancer, regardless of the tumor type.

Camus

421,950 次观看 • 9 个月前

Dr. Patrick Soon-Shiong reveals the "missing link" in cancer medicine that’s been hiding in plain sight for 450 million years of evolution: Natural Killer (NK) cells — your body’s built-in cancer assassins. Just like red blood cells prevent death from lack of oxygen, NK cells (and T cells) are designed to destroy cancer cells. Yet we’ve ignored them for most of medical history. In 2012, the National Cancer Institute reviewed 240 molecules and declared IL-15 the single most important one for curing cancer — because it supercharges NK cells and T cells. The problem? No one could deliver IL-15 safely and effectively… until Anktiva. 1:51 clip embedded — his passionate delivery makes the breakthrough feel like the missing piece we’ve overlooked for decades. Cancer isn’t just about killing tumors. It’s about waking up the immune system we were born with.
1:51

Dr. Patrick Soon-Shiong reveals the "missing link" in cancer medicine that’s been hiding in plain sight for 450 million years of evolution: Natural Killer (NK) cells — your body’s built-in cancer assassins. Just like red blood cells prevent death from lack of oxygen, NK cells (and T cells) are designed to destroy cancer cells. Yet we’ve ignored them for most of medical history. In 2012, the National Cancer Institute reviewed 240 molecules and declared IL-15 the single most important one for curing cancer — because it supercharges NK cells and T cells. The problem? No one could deliver IL-15 safely and effectively… until Anktiva. 1:51 clip embedded — his passionate delivery makes the breakthrough feel like the missing piece we’ve overlooked for decades. Cancer isn’t just about killing tumors. It’s about waking up the immune system we were born with.

Camus

38,499 次观看 • 6 个月前

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?
3:46

Megyn Kelly sat down with Dr. Patrick Soon-Shiong to discuss his revolutionary cancer protocol—a treatment that has already extended lives by years for patients with terminal diagnoses, including the late Senator Harry Reid. The Science Behind the Breakthrough Dr. Soon-Shiong’s approach challenges conventional cancer treatments like chemotherapy and radiation, which destroy the immune system’s natural killer (NK) cells and T-cells—critical for fighting cancer. His BioStripe treatment works by rebuilding the immune system, even in patients who have exhausted all other options. Real Patients, Miraculous Results Merkel cell carcinoma (5th-line treatment): Complete remission—patient lived 6+ years and didn’t die from cancer. Bladder cancer: Patients still alive 10-11 years later. Triple-negative breast cancer: Multiple complete remissions. Metastatic pancreatic cancer: One patient disease-free after 5 years, now 6+ years and counting. FDA Roadblocks & Lost Time Despite undeniable success, Dr. Soon-Shiong faced years of resistance from regulators. In 2015, he proposed testing his method before chemo/radiation—but the FDA insisted on starting with end-stage patients. After 700,000 pages of submissions, approval finally came in late 2024. The Future: Beyond Cancer This treatment isn’t just for cancer—it’s showing promise against sepsis and severe infections. One recent case: A Valley Fever patient on a ventilator, given last rites—fully recovered after treatment. The Urgent Question Why is bureaucracy slowing down a therapy that could save millions? With pancreatic cancer, glioblastoma, and lung cancer patients still dying every day, how many more lives could have been saved if this had been fast-tracked?

Camus

615,291 次观看 • 1 年前

Groundbreaking Cancer research by Dr. Andrea Cercek. Tumors “vanished” in 14 consecutive patients. New data shows another complete 100% response, in all 49 patients. None of her patients needed surgery, chemo or radiation. A monoclonal antibody with “breakthrough status” from the FDA... a new immunotherapy paradigm is evolving, steering the ship away from toxic treatments. Dr. Patrick Soon-Shiong recently said that system destroys the very cells (NK Cells) which protect your body against cancer, mentioning “we’ve been doing it wrong”. New data that emphasises his point: Dr. Andrea Cercek - “The updated data... we treated 49 patients... all 49 patients had a clinical complete response... all 49 of them chose to undergo NON OPERATIVE management... we have not had the issue of taking anyone to surgery”
3:25

Groundbreaking Cancer research by Dr. Andrea Cercek. Tumors “vanished” in 14 consecutive patients. New data shows another complete 100% response, in all 49 patients. None of her patients needed surgery, chemo or radiation. A monoclonal antibody with “breakthrough status” from the FDA... a new immunotherapy paradigm is evolving, steering the ship away from toxic treatments. Dr. Patrick Soon-Shiong recently said that system destroys the very cells (NK Cells) which protect your body against cancer, mentioning “we’ve been doing it wrong”. New data that emphasises his point: Dr. Andrea Cercek - “The updated data... we treated 49 patients... all 49 patients had a clinical complete response... all 49 of them chose to undergo NON OPERATIVE management... we have not had the issue of taking anyone to surgery”

Humanspective

16,695 次观看 • 2 个月前

Dr. Patrick Soon-Shiong Exposes the Cancer Treatment Lie: "Chemo & Radiation Destroy Your Body’s Best Defense—Here’s the Breakthrough That Actually Works" For decades, the world fought cancer with two brutal weapons: chemotherapy and radiation. But what if these treatments weaken the very system designed to save you? Hidden in your body for 460 million years are natural killer cells—your immune system’s elite soldiers against cancer. Yet chemo, radiation, steroids, and even newer drugs like Temodol cripple these cells. One radiation dose can shut them down for a year—leaving patients defenseless when they need protection most. Now, the game has changed. After battling Big Pharma, FDA roadblocks, and systemic resistance, Dr. Soon-Shiong’s team has pioneered a single-injection "Bio-Shield" therapy that activates your body’s natural cancer-fighting army. The results? ✅ Bladder cancer patients disease-free for 10+ years ✅ No toxic chemo or radiation side effects ✅ Potential to treat long COVID, HIV & sepsis The Biden administration blocked this breakthrough—along with COVID treatments—but the dam has broken. The future of medicine isn’t poisoning the body to save it. It’s unleashing the power God put inside us. The full story drops in Cancer Decoded. Follow to learn how we’re ending the era of suffering—and saving millions.
3:48

Dr. Patrick Soon-Shiong Exposes the Cancer Treatment Lie: "Chemo & Radiation Destroy Your Body’s Best Defense—Here’s the Breakthrough That Actually Works" For decades, the world fought cancer with two brutal weapons: chemotherapy and radiation. But what if these treatments weaken the very system designed to save you? Hidden in your body for 460 million years are natural killer cells—your immune system’s elite soldiers against cancer. Yet chemo, radiation, steroids, and even newer drugs like Temodol cripple these cells. One radiation dose can shut them down for a year—leaving patients defenseless when they need protection most. Now, the game has changed. After battling Big Pharma, FDA roadblocks, and systemic resistance, Dr. Soon-Shiong’s team has pioneered a single-injection "Bio-Shield" therapy that activates your body’s natural cancer-fighting army. The results? ✅ Bladder cancer patients disease-free for 10+ years ✅ No toxic chemo or radiation side effects ✅ Potential to treat long COVID, HIV & sepsis The Biden administration blocked this breakthrough—along with COVID treatments—but the dam has broken. The future of medicine isn’t poisoning the body to save it. It’s unleashing the power God put inside us. The full story drops in Cancer Decoded. Follow to learn how we’re ending the era of suffering—and saving millions.

Camus

127,084 次观看 • 1 年前

Chris Cuomo went dead silent on NewsNation when Dr. Patrick Soon-Shiong unveiled these real before-and-after brain tumor scans during their explosive interview. The patient? Had already exhausted surgery, radiation, and every round of chemotherapy—total failure. Then came this game-changing protocol: zero high-dose chemo, zero radiation in the core treatment. Result? Tumor visibly dissolving in mere months. Dr. Soon-Shiong to Cuomo: “For the first time in medical history, we’re flipping the switch on your own killer T-cells—the body’s deadliest cancer assassins—instead of nuking the immune system with the old high-dose hammer.” The mechanism? Micro-doses of legacy therapies deployed like a spotlight, “smoking out” the tumor to expose it... unleashing the patient’s primed natural killer cells to track, target, and obliterate. - FDA greenlit for bladder cancer - Phase 2/3 trials wrapped or in flight for pancreatic, triple-negative breast, lung, head & neck, plus 10+ more tumor fronts - Nearly 1,000 patients treated off-label via compassionate access, with stories of multi-year survival where docs gave months No hype from the doc: “This isn’t a silver bullet or one-and-done. It’s a seismic shift—from collateral-damage chemo wars to immune-system mastery.” Part of NewsNation’s must-watch special “Killing Cancer: The Power Within”—airing breakthroughs that could redefine the fight. If you’ve ever wondered what’s next for oncology, these scans demand your 123 seconds. Watch the full clip. What hits you hardest?
2:03

Chris Cuomo went dead silent on NewsNation when Dr. Patrick Soon-Shiong unveiled these real before-and-after brain tumor scans during their explosive interview. The patient? Had already exhausted surgery, radiation, and every round of chemotherapy—total failure. Then came this game-changing protocol: zero high-dose chemo, zero radiation in the core treatment. Result? Tumor visibly dissolving in mere months. Dr. Soon-Shiong to Cuomo: “For the first time in medical history, we’re flipping the switch on your own killer T-cells—the body’s deadliest cancer assassins—instead of nuking the immune system with the old high-dose hammer.” The mechanism? Micro-doses of legacy therapies deployed like a spotlight, “smoking out” the tumor to expose it... unleashing the patient’s primed natural killer cells to track, target, and obliterate. - FDA greenlit for bladder cancer - Phase 2/3 trials wrapped or in flight for pancreatic, triple-negative breast, lung, head & neck, plus 10+ more tumor fronts - Nearly 1,000 patients treated off-label via compassionate access, with stories of multi-year survival where docs gave months No hype from the doc: “This isn’t a silver bullet or one-and-done. It’s a seismic shift—from collateral-damage chemo wars to immune-system mastery.” Part of NewsNation’s must-watch special “Killing Cancer: The Power Within”—airing breakthroughs that could redefine the fight. If you’ve ever wondered what’s next for oncology, these scans demand your 123 seconds. Watch the full clip. What hits you hardest?

Camus

62,314 次观看 • 8 个月前

Dr. Patrick Soon-Shiong to Megyn Kelly: For 75 years we've treated cancer like a war—nuking tumors with poisons (chemo) and radiation while simultaneously destroying the immune system's natural killer cells and T-cells. The vicious cycle: Chemo → anemia → give Epogen → more chemo → wipe out neutrophils → give Neupogen → more chemo → destroy more lymphocytes/NK cells. FDA's gold standard? Maximum Tolerated Dose (MTD) — push the poison just below what kills the patient, measure tumor shrinkage (response rate), but ignore overall survival. Soon-Shiong: “The tumor shrinks… but the patient dies. We’re not really interested in overall survival as an endpoint. That is today’s thinking.” Megyn Kelly: “It seems to be a willing choice because we’ve gone so long without making much progress.” Clip from this 2:33 bombshell — the cancer “war” paradigm laid bare. Is MTD + response-rate obsession the reason we’re still losing the fight? Or is this the best we’ve got until something radically better arrives? Your take—seriously, drop it below.
2:33

Dr. Patrick Soon-Shiong to Megyn Kelly: For 75 years we've treated cancer like a war—nuking tumors with poisons (chemo) and radiation while simultaneously destroying the immune system's natural killer cells and T-cells. The vicious cycle: Chemo → anemia → give Epogen → more chemo → wipe out neutrophils → give Neupogen → more chemo → destroy more lymphocytes/NK cells. FDA's gold standard? Maximum Tolerated Dose (MTD) — push the poison just below what kills the patient, measure tumor shrinkage (response rate), but ignore overall survival. Soon-Shiong: “The tumor shrinks… but the patient dies. We’re not really interested in overall survival as an endpoint. That is today’s thinking.” Megyn Kelly: “It seems to be a willing choice because we’ve gone so long without making much progress.” Clip from this 2:33 bombshell — the cancer “war” paradigm laid bare. Is MTD + response-rate obsession the reason we’re still losing the fight? Or is this the best we’ve got until something radically better arrives? Your take—seriously, drop it below.

Camus

29,299 次观看 • 4 个月前

You are looking at a human brain tumor literally melting away in months. Before → After scans just released by Dr. Patrick Soon-Shiong, the billionaire surgeon who invented Abraxane and owns the LA Times. This patient had already failed maximum radiation, chemotherapy, and surgery. Then something completely new happened: Zero high-dose chemo. Zero radiation. Just low-dose “smoke-out” therapy + one FDA-approved molecule that does what nothing in medical history has ever done before… …it turns YOUR own natural killer cells and memory T-cells into a search-and-destroy army, without switching on the “suppressor cells” that normally paralyze the immune system. Exact words from the FDA-approved label of the drug (Anktiva/nogapendekin alfa): “Expands NK cells and CD8+ T cells without expansion of Treg cells.” Dr. Soon-Shiong: “For the first time in the history of medicine we have an approved treatment whose job is to fix the immune system itself — not poison the cancer and the patient at the same time.” Already approved in bladder cancer. Already trialed in pancreatic, triple-negative breast, lung, sarcoma, head & neck… with the same immune mechanism working every single time. Yet because cancer bureaucracy demands a separate decade-long trial for every tumor type, dying patients can only get it one compassionate-use plea at a time. Last week, former FDA Commissioner Scott Gottlieb, Vinay Prasad, and top health economists published a bombshell paper saying exactly this situation deserves immediate “plausibility-based” accelerated access when: - Mechanism is proven & FDA-affirmed - Safety established across thousands of doses - Early efficacy signals are strong Watch the clip. See the scans vanish with your own eyes. Listen to the man who spent 10 years and half a billion dollars proving it works. The real question now burning through oncology groups tonight: If a drug reliably wakes up the same killer cells in every human being… why are we still telling people with 8 weeks left that they have to wait 8 years? Full video below (brain scans + Dr. Patrick Soon-Shiong explaining the paradigm shift that just broke 100 years of cancer dogma). This is not medical advice. This therapy is FDA-approved for specific indications. All treatment decisions must be made with your oncologist. Post shares publicly available science and approved labeling only.
3:59

You are looking at a human brain tumor literally melting away in months. Before → After scans just released by Dr. Patrick Soon-Shiong, the billionaire surgeon who invented Abraxane and owns the LA Times. This patient had already failed maximum radiation, chemotherapy, and surgery. Then something completely new happened: Zero high-dose chemo. Zero radiation. Just low-dose “smoke-out” therapy + one FDA-approved molecule that does what nothing in medical history has ever done before… …it turns YOUR own natural killer cells and memory T-cells into a search-and-destroy army, without switching on the “suppressor cells” that normally paralyze the immune system. Exact words from the FDA-approved label of the drug (Anktiva/nogapendekin alfa): “Expands NK cells and CD8+ T cells without expansion of Treg cells.” Dr. Soon-Shiong: “For the first time in the history of medicine we have an approved treatment whose job is to fix the immune system itself — not poison the cancer and the patient at the same time.” Already approved in bladder cancer. Already trialed in pancreatic, triple-negative breast, lung, sarcoma, head & neck… with the same immune mechanism working every single time. Yet because cancer bureaucracy demands a separate decade-long trial for every tumor type, dying patients can only get it one compassionate-use plea at a time. Last week, former FDA Commissioner Scott Gottlieb, Vinay Prasad, and top health economists published a bombshell paper saying exactly this situation deserves immediate “plausibility-based” accelerated access when: - Mechanism is proven & FDA-affirmed - Safety established across thousands of doses - Early efficacy signals are strong Watch the clip. See the scans vanish with your own eyes. Listen to the man who spent 10 years and half a billion dollars proving it works. The real question now burning through oncology groups tonight: If a drug reliably wakes up the same killer cells in every human being… why are we still telling people with 8 weeks left that they have to wait 8 years? Full video below (brain scans + Dr. Patrick Soon-Shiong explaining the paradigm shift that just broke 100 years of cancer dogma). This is not medical advice. This therapy is FDA-approved for specific indications. All treatment decisions must be made with your oncologist. Post shares publicly available science and approved labeling only.

Camus

1,010,104 次观看 • 8 个月前

🚨 CANCER SCAM EXPOSED: “Chemo Destroys the Very Cells That Could Save You.” 🚨 Dr. Patrick Soon-Shiong just dropped a bombshell: 🧬 “Chemo. Radiation. Even Temodol — they wipe out your natural killer cells, your body’s best defense against cancer.” 💥 One radiation dose can shut down your immune response for a YEAR. 💥 Steroids, chemo & Big Pharma’s drugs? They’re crippling your only shield. But the truth is out now—and it’s being called "Bio-Shield Therapy." A single injection that reawakens your cancer-killing cells. ✅ Patients with bladder cancer are disease-free 10+ years ✅ No toxic chemo or radiation ✅ Could treat long COVID, HIV & even sepsis ❌ Biden’s FDA blocked this. ❌ Big Pharma fought to bury it. Why? Because you can't patent the immune system God gave you. 🔥 The era of poisoning the body to “save it” is OVER. 🔥 The future of medicine is already here. 📢 FULL STORY in Cancer Decoded. Follow now to learn how we end the suffering—and save millions.
3:53

🚨 CANCER SCAM EXPOSED: “Chemo Destroys the Very Cells That Could Save You.” 🚨 Dr. Patrick Soon-Shiong just dropped a bombshell: 🧬 “Chemo. Radiation. Even Temodol — they wipe out your natural killer cells, your body’s best defense against cancer.” 💥 One radiation dose can shut down your immune response for a YEAR. 💥 Steroids, chemo & Big Pharma’s drugs? They’re crippling your only shield. But the truth is out now—and it’s being called "Bio-Shield Therapy." A single injection that reawakens your cancer-killing cells. ✅ Patients with bladder cancer are disease-free 10+ years ✅ No toxic chemo or radiation ✅ Could treat long COVID, HIV & even sepsis ❌ Biden’s FDA blocked this. ❌ Big Pharma fought to bury it. Why? Because you can't patent the immune system God gave you. 🔥 The era of poisoning the body to “save it” is OVER. 🔥 The future of medicine is already here. 📢 FULL STORY in Cancer Decoded. Follow now to learn how we end the suffering—and save millions.

Jim Ferguson

1,507,178 次观看 • 1 年前

Dr. Patrick Soon-Shiong was speaking pretty openly on 2Way’s Cancer Decoded about a long-standing frustration in cancer care. Standard treatments like checkpoint inhibitors, radiation, and chemo can exhaust or destroy your T-cells, the key immune fighters your body needs. But there’s real movement: late 2024, the FDA approved Anktiva (nogapendekin alfa inbakicept-pmln / N-803), an IL-15 receptor agonist. It works by expanding natural killer (NK) cells and memory CD8+ T-cells to help the immune system target hidden cancer cells more effectively, especially in BCG-unresponsive non-muscle invasive bladder cancer. He’s advocating for using low-dose traditional therapies in a smarter, immunomodulating way so the body can actually participate in the fight. This one really got to me. I’ve watched cancer hit people I care about and seen how draining the standard path can be. Hearing someone at his level talk about finally having new tools after 75 years feels like a genuine shift — hopeful, but also a reminder of how slow real change comes in medicine. Cancer treatment has followed the same heavy playbook for generations. If we can better protect and activate the immune system while treating the disease, it could mean less suffering and better real-world outcomes. What do you think — are we at the beginning of a smarter era in cancer treatment, or is it still too early to tell?
1:34

Dr. Patrick Soon-Shiong was speaking pretty openly on 2Way’s Cancer Decoded about a long-standing frustration in cancer care. Standard treatments like checkpoint inhibitors, radiation, and chemo can exhaust or destroy your T-cells, the key immune fighters your body needs. But there’s real movement: late 2024, the FDA approved Anktiva (nogapendekin alfa inbakicept-pmln / N-803), an IL-15 receptor agonist. It works by expanding natural killer (NK) cells and memory CD8+ T-cells to help the immune system target hidden cancer cells more effectively, especially in BCG-unresponsive non-muscle invasive bladder cancer. He’s advocating for using low-dose traditional therapies in a smarter, immunomodulating way so the body can actually participate in the fight. This one really got to me. I’ve watched cancer hit people I care about and seen how draining the standard path can be. Hearing someone at his level talk about finally having new tools after 75 years feels like a genuine shift — hopeful, but also a reminder of how slow real change comes in medicine. Cancer treatment has followed the same heavy playbook for generations. If we can better protect and activate the immune system while treating the disease, it could mean less suffering and better real-world outcomes. What do you think — are we at the beginning of a smarter era in cancer treatment, or is it still too early to tell?

Camus

18,305 次观看 • 2 个月前

Dr. Patrick Soon-Shiong: We've ignored a key CBC metric for 75 years—Absolute Lymphocyte Count (ALC)—your body's count of cancer-fighting NK cells, T cells, memory T cells, B cells, dendritic cells (collectively lymphocytes). Low ALC ( 1,500–1,800 for immune "store." Chemo/radiation/COVID wipe it out—yet until now, nothing to fix it. His breakthrough: ANKTIVA (IL-15 superagonist, "BioShield") unlocks your body's factory to proliferate billions of these cells (FDA-approved for bladder cancer; expanded access/RMAT for lymphopenia reversal in trials). Lymphocytes are the forgotten guardians—ALC is like checking A1C or hemoglobin. Monitor it, boost via sleep/exercise/sunlight, and emerging therapies may restore what toxins deplete. Do you check your ALC on bloodwork? What's your level (or plan to ask next test)? Share experiences.
4:33

Dr. Patrick Soon-Shiong: We've ignored a key CBC metric for 75 years—Absolute Lymphocyte Count (ALC)—your body's count of cancer-fighting NK cells, T cells, memory T cells, B cells, dendritic cells (collectively lymphocytes). Low ALC ( 1,500–1,800 for immune "store." Chemo/radiation/COVID wipe it out—yet until now, nothing to fix it. His breakthrough: ANKTIVA (IL-15 superagonist, "BioShield") unlocks your body's factory to proliferate billions of these cells (FDA-approved for bladder cancer; expanded access/RMAT for lymphopenia reversal in trials). Lymphocytes are the forgotten guardians—ALC is like checking A1C or hemoglobin. Monitor it, boost via sleep/exercise/sunlight, and emerging therapies may restore what toxins deplete. Do you check your ALC on bloodwork? What's your level (or plan to ask next test)? Share experiences.

Camus

67,991 次观看 • 6 个月前

Complete Remission in Glioblastoma After Failed Treatments – A World First? In a remarkable medical milestone, a patient with end-stage glioblastoma—who had failed surgery, radiation, and Temodar—achieved a complete remission in Dr. Patrick Soon-Shiong’s groundbreaking trial. 🔬 Before vs. After MRI: ◀️ LEFT (Before): Tumor crushing the brain’s ventricle, a grim prognosis with no options left. ▶️ RIGHT (After): Tumor virtually gone, ventricle fully reopened—only minimal scarring remains. Dr. Soon-Shiong called this "unprecedented" in glioblastoma, a disease where complete responses at this stage were once thought impossible. 💡 What’s Next? Due to this stunning result, the trial is expanding from 20 to 70 patients. If confirmed, this could rewrite the playbook for treating aggressive brain tumors. "We are witnessing what could be a paradigm shift in oncology," said Dr. Soon-Shiong. "This isn’t just a partial response—it’s a complete remission in a patient who had exhausted every option." Stay tuned for updates as this potentially practice-changing study unfolds. Hope is no longer a theory—it’s in the data.
1:15

Complete Remission in Glioblastoma After Failed Treatments – A World First? In a remarkable medical milestone, a patient with end-stage glioblastoma—who had failed surgery, radiation, and Temodar—achieved a complete remission in Dr. Patrick Soon-Shiong’s groundbreaking trial. 🔬 Before vs. After MRI: ◀️ LEFT (Before): Tumor crushing the brain’s ventricle, a grim prognosis with no options left. ▶️ RIGHT (After): Tumor virtually gone, ventricle fully reopened—only minimal scarring remains. Dr. Soon-Shiong called this "unprecedented" in glioblastoma, a disease where complete responses at this stage were once thought impossible. 💡 What’s Next? Due to this stunning result, the trial is expanding from 20 to 70 patients. If confirmed, this could rewrite the playbook for treating aggressive brain tumors. "We are witnessing what could be a paradigm shift in oncology," said Dr. Soon-Shiong. "This isn’t just a partial response—it’s a complete remission in a patient who had exhausted every option." Stay tuned for updates as this potentially practice-changing study unfolds. Hope is no longer a theory—it’s in the data.

Camus

42,773 次观看 • 1 年前

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.
2:53

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Camus

38,936 次观看 • 10 个月前

Dr. Patrick Soon-Shiong raises alarming concerns in this 3:06 clip about what he believes are major drivers of rising cancer rates—and a potential preventive tool: 1. Radiation exposure (e.g., military pilots in B-2 bombers) wipes out natural killer cells → allows cancer cells to grow. 2. Persistent COVID/spike protein (from infection or vaccine) found in tumor tissue → may act like HPV or hepatitis as a cancer trigger. 3. Undiagnosed Lynch syndrome (1–2 million Americans unaware) → 80% higher risk of colon/endometrial cancer. He highlights Anktiva (N-803) as a breakthrough: - Chosen by NCI to prevent Lynch syndrome cancers (trials at Mayo, Cleveland Clinic already completed). - Tested to prevent radiation-induced cancer. - Yet still waiting on FDA action for broader prevention use after a year. Frustrating to him: A molecule approved for treatment in Saudi Arabia, backed by major academic centers for prevention, sitting in regulatory limbo. Watch the full clip and decide for yourself. What do you make of the radiation, COVID, and genetic predisposition links he’s drawing? Any personal thoughts or questions on Anktiva/prevention? Drop them below.
3:06

Dr. Patrick Soon-Shiong raises alarming concerns in this 3:06 clip about what he believes are major drivers of rising cancer rates—and a potential preventive tool: 1. Radiation exposure (e.g., military pilots in B-2 bombers) wipes out natural killer cells → allows cancer cells to grow. 2. Persistent COVID/spike protein (from infection or vaccine) found in tumor tissue → may act like HPV or hepatitis as a cancer trigger. 3. Undiagnosed Lynch syndrome (1–2 million Americans unaware) → 80% higher risk of colon/endometrial cancer. He highlights Anktiva (N-803) as a breakthrough: - Chosen by NCI to prevent Lynch syndrome cancers (trials at Mayo, Cleveland Clinic already completed). - Tested to prevent radiation-induced cancer. - Yet still waiting on FDA action for broader prevention use after a year. Frustrating to him: A molecule approved for treatment in Saudi Arabia, backed by major academic centers for prevention, sitting in regulatory limbo. Watch the full clip and decide for yourself. What do you make of the radiation, COVID, and genetic predisposition links he’s drawing? Any personal thoughts or questions on Anktiva/prevention? Drop them below.

Camus

70,270 次观看 • 6 个月前

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.
5:44

Dr. Patrick Soon-Shiong presents a fundamental paradigm shift in the war on cancer: we must stop destroying the immune system to save the body, and start supercharging it to achieve a permanent cure. The critical flaw of conventional chemotherapy and radiation is their inadvertent destruction of the very immune cells—the lymphocytes—designed to protect us. This often wins a battle but loses the war, leading to metastasis. The solution lies within us. Dr. Soon-Shiong’s work harnesses "God's design": the power of Natural Killer (NK) cells and T-cells. The breakthrough is two-fold: 1. The Activation Key: For the first time, we can effectively activate these cells using a sustained-release form of IL-15, a natural protein. A single injection can create a tenfold increase in the body's innate cancer-killing army. 2. The Army Expansion: We can now draw a patient's blood, grow billions of targeted NK cells in a lab, and reinfuse them, creating a supercharged, augmented immune response. This is not an incremental improvement. It is a move away from the failed strategy of attacking cancer from the inside-out—blocking internal pathways that cancer easily bypasses—to shattering it from the outside-in. The result is data that speaks to a potential cure: patients with metastatic pancreatic cancer alive and disease-free after five years; bladder cancer patients thriving with their organs intact a decade after treatment; long-term remission in aggressive Merkel cell carcinoma. This approach teaches the immune system "T-cell memory," creating a permanent, living surveillance system that stands guard against recurrence. This is the path to long-term survival with quality of life.

Camus

103,022 次观看 • 10 个月前

The Pillars of Cancer Treatment Are a Lie. Chemo and Radiation Aren't Just Brutal—They're Actively Destroying Your Natural Killer Cells, the Very Thing Standing Between You and Cancer. A stunning revelation from Dr. Patrick Soon-Shiong that reframes our entire battle against cancer. He shares a truth 460 million years in the making. Within every one of us is an ancient gift, a cell bestowed by the very process of creation: the Natural Killer (NK) cell. Dr. Soon-Shiong explains that this cell is our fundamental biological shield, the key reason humanity has survived infection, trauma, and cancer across millennia. Yet, for decades, modern medicine has waged a devastating war on this very protector. How? With the very pillars of our oncological arsenal: high-dose chemotherapy, radiation, steroid therapy, and even newer modalities. These treatments, while aimed at cancer, systematically destroy the NK cells designed to defend us. A single dose of radiation can obliterate this natural defense for a year, leaving patients vulnerable. Dr. Soon-Shiong presents a paradigm-shattering question: What if, instead of attacking the body’s innate protection, we learned to unlock and unleash it? The answer is here. After a lifetime of research, a method has been discovered and approved to activate the body as its own factory. A single intervention—a “bio-shield”—that proliferates these natural killer cells, empowering them to do what they were designed to do: protect you from cancer. The results? Real patients with bladder cancer, free of disease for a decade. This is not a future promise. This is a present reality, approved in 2024. Dr. Soon-Shiong credits the current administration for its role in moving this breakthrough forward for the entire nation. The era of destroying the body to save it is ending. The era of activating our 460-million-year-old innate defense has begun.
2:58

The Pillars of Cancer Treatment Are a Lie. Chemo and Radiation Aren't Just Brutal—They're Actively Destroying Your Natural Killer Cells, the Very Thing Standing Between You and Cancer. A stunning revelation from Dr. Patrick Soon-Shiong that reframes our entire battle against cancer. He shares a truth 460 million years in the making. Within every one of us is an ancient gift, a cell bestowed by the very process of creation: the Natural Killer (NK) cell. Dr. Soon-Shiong explains that this cell is our fundamental biological shield, the key reason humanity has survived infection, trauma, and cancer across millennia. Yet, for decades, modern medicine has waged a devastating war on this very protector. How? With the very pillars of our oncological arsenal: high-dose chemotherapy, radiation, steroid therapy, and even newer modalities. These treatments, while aimed at cancer, systematically destroy the NK cells designed to defend us. A single dose of radiation can obliterate this natural defense for a year, leaving patients vulnerable. Dr. Soon-Shiong presents a paradigm-shattering question: What if, instead of attacking the body’s innate protection, we learned to unlock and unleash it? The answer is here. After a lifetime of research, a method has been discovered and approved to activate the body as its own factory. A single intervention—a “bio-shield”—that proliferates these natural killer cells, empowering them to do what they were designed to do: protect you from cancer. The results? Real patients with bladder cancer, free of disease for a decade. This is not a future promise. This is a present reality, approved in 2024. Dr. Soon-Shiong credits the current administration for its role in moving this breakthrough forward for the entire nation. The era of destroying the body to save it is ending. The era of activating our 460-million-year-old innate defense has begun.

Camus

150,903 次观看 • 10 个月前